Lack of diversity in clinical trials undermines outcomes

07/9/2013 | PharmaTimes (U.K.)

Low participation of minority populations in clinical trials undermines the health care system, says Dr. Bruce Moskowitz, founder of Race and ethnicity may play a role in disease risk as well as drug response, but minorities remain underrepresented in clinical trials, Moskowitz says. Mistrust, lack of insurance, low awareness of clinical trial opportunities, language and health literacy barriers, eligibility criteria that exclude patients with multiple conditions, and other practical considerations keep many minorities from participating in clinical trials.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA